Novel Proteasome Inhibitors and Histone Deacetylase Inhibitors: Progress in Myeloma Therapeutics

Author： Chhabra Saurabh  

Publisher： MDPI

E-ISSN： 1424-8247|10|2|40-40

ISSN： 1424-8247

Source： Pharmaceuticals, Vol.10, Iss.2, 2017-04, pp. : 40-40

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Histone Deacetylase Inhibitors as Anticancer Drugs

By Eckschlager Tomas   Plch Johana   Stiborova Marie   Hrabeta Jan  

International Journal of Molecular Sciences, Vol. 18, Iss. 7, 2017-07 ,pp. : 1414-1414

MDPI

Access to resources Recommend Favorite

Clinical Toxicities of Histone Deacetylase Inhibitors

By Subramanian Srividya   Bates Susan E.   Wright John J.   Espinoza-Delgado Igor   Piekarz Richard L.  

Pharmaceuticals, Vol. 3, Iss. 9, 2010-08 ,pp. : 2751-2767

MDPI

Access to resources Recommend Favorite

Improved Histone Deacetylase Inhibitors as Therapeutics for the Neurodegenerative Disease Friedreich’s Ataxia: A New Synthetic Route

By Xu Chunping   Soragni Elisabetta   Jacques Vincent   Rusche James R.   Gottesfeld Joel M.  

Pharmaceuticals, Vol. 4, Iss. 12, 2011-12 ,pp. : 1578-1590

MDPI

Access to resources Recommend Favorite

Clinical Use of Proteasome Inhibitors in the Treatment of Multiple Myeloma

By Merin Noah M.   Kelly Kevin R.  

Pharmaceuticals, Vol. 8, Iss. 1, 2014-12 ,pp. : 1-20

MDPI

Access to resources Recommend Favorite

Overview of Histone Deacetylase Inhibitors in Haematological Malignancies

By Bishton Mark J.   Johnstone Ricky W.   Dickinson Michael   Harrison Simon   Prince H. Miles  

Pharmaceuticals, Vol. 3, Iss. 8, 2010-08 ,pp. : 2674-2688

MDPI

Access to resources Recommend Favorite